FDA seeks to tighten screening of conflicts (Chicago Tribune)
Stricter guidelines for advisory panels The U.S. Food and Drug Administration on Wednesday proposed guidelines that would disqualify doctors and scientific researchers from serving on its advisory panels if they received financial benefits exceeding $50,000 from drug and medical device companies over the course of a year.

FDA rules toughen on experts (The Star-Ledger)
The Food and Drug Administration yesterday proposed tougher guidelines to avoid conflicts of interest by scientific experts who advise the agency on the approval of new prescription drugs and medical devices.